142 related articles for article (PubMed ID: 4468627)
41. [Osmotic resistance of the thrombocytes and capillary resistance in hepatocholecystitis and liver cirrhosis].
Starodub EM
Lab Delo; 1968; 9():535-7. PubMed ID: 4184954
[No Abstract] [Full Text] [Related]
42. [Value of determining erythrocyte membrane permeability in the diagnosis of chronic liver diseases].
Kolmakov VN; Radchenko VG
Ter Arkh; 1982; 54(2):59-62. PubMed ID: 7071775
[No Abstract] [Full Text] [Related]
43. [Significance of various diagnostic parameters in chronic liver diseases].
Heinicke HJ
Z Gesamte Inn Med; 1973 Feb; 28(4):93-101. PubMed ID: 4540734
[No Abstract] [Full Text] [Related]
44. Immunoelectrophoresis in chronic hepatic affections.
Fronescu E; Almăsan E; Tudor R
Rom Med Rev; 1966; 20(2):12-22. PubMed ID: 5960040
[No Abstract] [Full Text] [Related]
45. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
[TBL] [Abstract][Full Text] [Related]
46. [Pathogenesis of disorder of glucose tolerance and diabetes mellitus in patients with chronic hepatitis and liver cirrhosis].
Moskvichev AM; Shlimovich PB
Sov Med; 1975 Sep; (9):110-4. PubMed ID: 1231013
[No Abstract] [Full Text] [Related]
47. [Chronic aggressive hepatitis].
Creutzfeldt W
Dtsch Med Wochenschr; 1973 Mar; 98(11):580-1. PubMed ID: 4695004
[No Abstract] [Full Text] [Related]
48. Clinical value of the determination of fasting glycocholic acid serum levels in patients with liver diseases. A comparison with standard liver tests.
Collazos J; Mendarte U; De Miguel J
Gastroenterol Clin Biol; 1993; 17(2):79-82. PubMed ID: 8500713
[TBL] [Abstract][Full Text] [Related]
49. Chronic hepatitis.
Williams R
Trans Med Soc Lond; 1968; 84():173-81. PubMed ID: 5708151
[No Abstract] [Full Text] [Related]
50. [Adenohypophyseal hormones in chronic liver diseases].
Shlimovich PB
Klin Med (Mosk); 1979 Jun; 57(6):70-6. PubMed ID: 459387
[No Abstract] [Full Text] [Related]
51. [On enzymatic blood ammonia determination in liver patients with and without hepatic coma].
Müting D; Buhl H; Eschrich W; Reikowski H
Med Welt; 1966 Oct; 43():2288-93. PubMed ID: 5977110
[No Abstract] [Full Text] [Related]
52. [ABO and RH-HR blood-group systems in acute and chronic liver diseases].
Sowa J; Odrobina S
Przegl Lek; 1982 Sep; 39(8):547-50. PubMed ID: 6813916
[No Abstract] [Full Text] [Related]
53. [Diagnostic value of serum bile acids in chronic diseases of the liver].
Testa R; Bocchini R; Dellepiane F; Dodero M; Celle G
Med Chir Dig; 1980; 9(2):95-7. PubMed ID: 7401731
[No Abstract] [Full Text] [Related]
54. [On lipoprotein lipase activity, serum lipids and the effect of heparin on the blood sugar level in atrophic liver cirrhosis and chronic hepatitis].
Bosadjiewa E; Warbanow G; Markowski S; Beltschew L; Russinow E
Z Gesamte Inn Med; 1967 Jul; 22(13):393-6. PubMed ID: 5595619
[No Abstract] [Full Text] [Related]
55. Hemostasis and global fibrinolytic capacity in chronic liver disease.
Aytac S; Turkay C; Bavbek N; Kosar A
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):623-6. PubMed ID: 17890949
[TBL] [Abstract][Full Text] [Related]
56. [Clinico-diagnostic significance of the determination of bile acids in chronic liver diseases].
Andreuzzi B; Vai C; Santese R; Andreuzzi P; Cantoni L
Minerva Med; 1984 Mar; 75(13):749-56. PubMed ID: 6717831
[TBL] [Abstract][Full Text] [Related]
57. [Significance of serum carnitine in patients with liver diseases].
Lin XH; Jiao LL; Xu GB; Tian GS
Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):367-9. PubMed ID: 16732913
[TBL] [Abstract][Full Text] [Related]
58. Endogenous digoxin-like substance in liver failure.
Lucena MI; Andrade RJ; Fraile JM; Alcantara R; Gonzalez-Correa JA; De La Cuesta FS
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):567-9. PubMed ID: 7834165
[TBL] [Abstract][Full Text] [Related]
59. [Retention of bromsulphalein in the serum during various stages of activity in chronic hepatitis and liver cirrhosis].
Vido I; Wildhirt E
Cesk Gastroenterol Vyz; 1968 Oct; 22(7):433-7. PubMed ID: 5703995
[No Abstract] [Full Text] [Related]
60. [Fasting and postprandial serum bile acids in chronic liver diseases].
Testa R; Dellepiane F; Rovida S; Lapertosa G; Domina AR; Virdis MG; Risso D; Mansi C; Picciotto A; Savarino V; Celle G
Minerva Dietol Gastroenterol; 1982; 28(3):195-200. PubMed ID: 7145170
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
